Eli Lilly to Do Added Study of Experimental Alzheimer’s Drug

Eli Lilly to Do Added Study of Experimental Alzheimer’s Drug

Victor J. Blue/Bloomberg

Eli Lilly & Co. fell 4 percent to $48.55 in early trading in New York.